Immunogen reported $84.12M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Abbvie ABBV:US $ 32521M 2673M
Agios Pharmaceuticals AGIO:US $ 45.79M 14.03M
Amgen AMGN:US $ 12886M 702M
Astellas Pharma 4503:JP Y 687411M 89435M
AstraZeneca AZN:LN 22740M 146M
Bluebird Bio BLUE:US $ 142.89M 10.1M
Bristol Myers Squibb BMY:US $ 22821M 953M
Cerulean Pharma CERU:US $ 16.4M 0.34M
Eli Lilly And LLY:US $ 13386M 1666.7M
Emergent Biosolutions EBS:US $ 249.2M 124.6M
Exelixis EXEL:US $ 289.08M 48.51M
Halozyme Therapeutics HALO:US $ 111.69M 5.46M
Heron Therapeutics HRTX:US $ 93M 21.94M
Immunogen IMGN:US $ 84.12M 16.83M
Intrexon XON:US $ 25.6M 9.04M
Karyopharm Therapeutics KPTI:US $ 66.34M 7.38M
Macrogenics MGNX:US $ 67.1M 7.48M
Nektar Therapeutics NKTR:US $ 105.28M 20.08M
Novartis NVS:US $ 29807M 401M
Pfizer PFE:US $ 39268M 3403M
Regeneron Pharmaceuticals REGN:US $ 3007.6M 924.9M
Seattle Genetics SGEN:US $ 531.29M 37.56M